Rainbow Co., Ltd. received a warning letter: due to the known signs of significant impairment of the base plate glass production line, but failed to fulfill the letter Phi obligation in time
Financial Associated Press, Dec. 17 (Xinhua) -- rainbow shares announced that Shaanxi regulatory bureau of China Securities Regulatory Commission decided to take regulatory measures to issue warning letters to the company and Chen Zhongguo, Li Miao and long Tao. On August 28, 2020, the company disclosed an announcement to explain the provision for impairment of 771 million yuan for substrate glass production lines with signs of impairment. In June 2020, the company learned that significant impairment of substrate glass production line would lead to significant impairment loss of assets, but failed to fulfill the obligation of information disclosure in time.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's Road to Tackle Autoimmune Diseases Globally
The market of autoimmune diseases medication is vast both in China and overseas and presents great opportunities. However, the number of Chinese players specializing in autoimmune diseases is limited. This article introduced the autoimmune diseases medication market in China and explained why Chinese players are limited then give some recommendations on what efforts Chinese companies can make to compete with western players.
Oct 04, 2022 08:00 AM
Sep 30, 2022 05:31 PM
Aug 29, 2022 05:45 PM
Aug 09, 2022 04:42 PM
May 02, 2022 07:50 PM
Briefing Dec 27, 2021 03:29 PM
· Technology
The national development and Reform Commission and the Ministry of Commerce issued the 2021 negative list of foreign investment access to further deepen the opening of the manufacturing industry
Insight
Technology
Fremont Micro Devices Raises CNY 500 Million from Pre-IPO Funding Round
Fremont Micro Devices is a high-tech enterprise focusing on developing non-volatile memory products and high-efficiency power management solutions. It officially announced the completion of a CNY 500 million (USD 70.3 million) Pre-IPO financing round, led by Huaxun Found.
Sep 30, 2022 08:26 PM
Briefing Dec 27, 2021 01:39 PM
· Technology
In November, the export volume of Anhui new energy vehicles increased by more than 7 times year-on-year
Briefing Dec 19, 2021 12:59 PM
· Technology
The concept of power segmentation is stronger, and institutions pay attention to the list of individual stocks first
Briefing Dec 17, 2021 08:59 AM
· Technology
Yujing shares received a letter of concern: it is required to confirm whether there is any material information that should be disclosed but not disclosed
Insight
Healthcare
15 Companies to Watch in September 2022- Healthcare
Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in September 2022. And the following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, and the segments in which the startups operate.
Sep 30, 2022 12:32 PM
Healthcare
Insight Lifetech Completes Series D+ Equity Round
Insight Lifetech, a high-tech company dedicated to providing innovative solutions for cardiovascular disease precision intervention, will continue to provide more innovative products and services and provide changes to precision diagnosis and treatment of cardiovascular diseases.
Sep 30, 2022 12:20 PM
Briefing Dec 16, 2021 09:29 AM
· Healthcare
The net purchase of 11 shares was more than 100 million yuan, and Wuxi apptec was the most
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Consumer Staples
15 Chinese Companies to Watch in September 2022 – New Consumption
Oct 03, 2022 06:17 PM
Insight
In-depth